Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice
Accenture
Moodys
Fuji
Medtronic
Deloitte
Johnson and Johnson
Mallinckrodt
Queensland Health

Generated: August 18, 2017

DrugPatentWatch Database Preview

Braintree Company Profile

« Back to Dashboard

What is the competitive landscape for BRAINTREE, and when can generic versions of BRAINTREE drugs launch?

BRAINTREE has six approved drugs.

There are three US patents protecting BRAINTREE drugs.

There are twenty patent family members on BRAINTREE drugs in thirteen countries.

Summary for Applicant: Braintree

Patents:3
Tradenames:7
Ingredients:6
NDAs:6
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Braintree
GOLYTELY
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous
FOR SOLUTION;ORAL019011-001Jul 13, 1984AARXYesYes► Subscribe► Subscribe► Subscribe
Braintree
AXID
nizatidine
SOLUTION;ORAL021494-001May 25, 2004DISCNYesNo► Subscribe► SubscribeY ► Subscribe
Braintree
NULYTELY
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
FOR SOLUTION;ORAL019797-001Apr 22, 1991AARXYesYes► Subscribe► Subscribe► Subscribe
Braintree Labs
SUPREP BOWEL PREP KIT
magnesium sulfate; potassium sulfate; sodium sulfate
SOLUTION;ORAL022372-001Aug 5, 2010AARXYesYes► Subscribe► SubscribeY ► Subscribe
Braintree
NULYTELY-FLAVORED
polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride
FOR SOLUTION;ORAL019797-002Nov 18, 1994AARXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for BRAINTREE drugs

Drugname Dosage Strength Tradename Submissiondate
sodium sulfate, potassium sulfate and magnesium sulfate
Oral Solution17.5 g/3.13 g/1.6 g per bottle
SUPREP BOWEL PREP KIT
11/8/2010
polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride and bisacodyl
For Oral Solution and Delayed-release Tablet210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg (1 Tablet Regimen)
HALFLYTELY
7/30/2010
nizatidine
Oral Solution15 mg/mL
AXID
5/14/2008
polyethylene glycol 3350, sodium chloride, sodium bicarbonate, potassium chloride and bisacodyl
For Oral Solution and Delayed-210 g, 5.6 g, 0.74 g, 2.86 g and 5 mg
HALFLYTELY
1/28/2008

International Patent Family for Braintree Drugs

Country Document Number Estimated Expiration
Canada2484303► Subscribe
World Intellectual Property Organization (WIPO)2004009077► Subscribe
Spain2441890► Subscribe
Cyprus1114745► Subscribe
Slovenia1499331► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Braintree Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C/GB01/006United Kingdom► SubscribePRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
2012 00035Denmark► SubscribePRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
0130010 00080Estonia► SubscribePRODUCT NAME: NAATRIUMSULFAAT, MAGNEESIUMSULFAATHEPTAHUEDRAAT JA;REG NO/DATE: RR-4/5 04.03.2013
C0055France► SubscribePRODUCT NAME: SULFATE DE SODIUM ANHYDRE, SULFATE DE MAGNESIUM HEPTAHYDRATE, SULFATE DE POTASSIUM; NAT. REGISTRATION NO/DATE: NL41696 20130426; FIRST REGISTRATION: 434323 20130220
12/048Ireland► SubscribePRODUCT NAME: A COMBINATION PRODUCT COMPRISING ASPIRIN AND ESOMEPRAZOLE MAGNESIUM TRIHYDRATE; NAT REGISTRATION NO/DATE: PA 970/063/001 20120831; FIRST REGISTRATION NO/DATE: 5402359; 5402367 5402375 20110812
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Chubb
Cerilliant
Express Scripts
Farmers Insurance
Covington
McKinsey
US Department of Justice
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot